Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1605)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3722)
  2. Department of Medicine (3691)
  3. Hematologic Malignancies, Division of (3687)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (389)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (105)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (325)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3722)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Modeling analysis for Ac-225 radioimmunotherapy of leukemia
    Meeting Abstract

    Sgouros, G.; Jurcic, J. G.; Cicic, D.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2008)

    Fulltext@MSK | Save
  • Sequential cytarabine and alpha-particle immunotherapy with bismuth-213 ((213)Bi)-labeled-HuM195 (lintuzumab) for acute myeloid leukemia (AML)
    Meeting Abstract

    Rosenblat, T.; McDevitt, M. R.; Mulford, D. A.; Pandit-Taskar, N.; Weiss, M. A.; Heaney, M. L.; Chanel, S.; Morgenstern, A.; Larson, S. M.; Scheinberg, D. A.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Depletion of vascular endothelial progenitor cells inhibits inflammation
    Meeting Abstract

    Penack, O.; Henke, E.; Suh, D.; King, C.; Smith, M. O.; Na, I. K.; Holland, A.; Ghosh, A.; Lu, S. X.; Jenq, R.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • The extracellular portion of the MUC16 cytoplasmic domain is detectable in ovarian carcinoma using a novel monoclonal antibody, 4H11
    Meeting Abstract

    Park, K. J.; Soslow, R. A.; Linkov, I.; Thapi, D.; Spriggs, D.
    Modern Pathology (2008)

    Fulltext@MSK | Save
  • The extracellular portion of the MUC16 cytoplasmic domain is detectable in ovarian carcinoma using a novel monoclonal antibody, 4H11
    Meeting Abstract

    Park, K. J.; Soslow, R.; Linkov, I.; Thapi, D.; Spriggs, D.
    Laboratory Investigation (2008)

    Fulltext@MSK | Save
  • OTT-MAL activates the Notch signaling transcription factor RBPJ and cooperates with mutant MPL to induce acute megakaryoblastic leukemia
    Meeting Abstract

    Mercher, T.; Raffel, G. D.; Moore, S. A.; Cornejo, M. G.; Baudry-Bluteau, D.; Cagnard, N.; Jesneck, J.; Pikman, Y.; Cullen, D. E.; Williams, I.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • NFIB: A gene consistently upregulated in MPD and frequently co-amplified with JAK2V617F augments growth of erythropoietin dependent cells
    Meeting Abstract

    Lin, X. Q.; Buzzai, M.; Levine, R. L.; Berkofsky-Fessler, W.; Zhang, W. J.; Ebert, B. L.; Gilliland, D. G.; Licht, J. D.
    Blood (2008)

    Fulltext@MSK | Save
  • Tumor-targeted human CD4(+) CD25(hi) regulatory T cells effectively inhibit T cell-mediated rejection of CD19(+) tumors in an in vivo xenotransplant tumor model
    Meeting Abstract

    Lee, J.; Sadelain, M.; Brentjens, R. J.
    Blood (2008)

    Fulltext@MSK | Save
  • Sequential administration of bortezomib, liposomal doxorubicin and dexamethasone (BDD) followed by thalidomide and dexamethasone (TD) results in rapid control of untreated high-risk multiple myeloma (MM) and improves depth of response
    Meeting Abstract

    Landau, H.; Hassoun, H.; Cohen, A.; Hoover, E.; Kewalramani, T.; Boruchov, A.; Klimek, V.; Reich, L.; Riedel, E.; Pandit-Taskar, N.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Elevations in creatine kinase occur frequently in patients treated with imatinib mesylate (Gleevec)
    Meeting Abstract

    Gordon, J. K.; Magid, S. K.; Berman, E.
    Arthritis and Rheumatism (2008)

    Fulltext@MSK | Save